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Abstract. Using the 20-meter shuttle run test (20mSRT) as a morbidity metric, we assessed whether Schistosoma
mansoni infectionwas associatedwith decreased aerobic capacity inUgandan children across a range of altitudes, either
at low (∼600 m) or high (∼1,000 m) altitudes. A total of 305 children were recruited from six schools within the Buliisa
District, Lake Albert, Uganda. A subset (n = 96) of these had been previously assessed and treated for schistosomiasis ±
malaria 2 weeks prior. Fitness scores on the 20mSRT were translated into VO2max using a standardized equation.
Unadjusted and multivariable-adjusted analyses were performed using VO2max as the primary outcome. Analysis of
fitness scores from 304 children, inclusive of the subset follow-up cohort, revealed a median VO2max of 45.4 mL kg−1
min−1 (interquartile range: 42.9–48.0 mL kg−1 min−1). Children residing at high altitudes demonstrated increased aerobic
capacities (46.3 versus 44.8 mL kg−1 min−1, P = 0.031). The prevalence of stunting, wasting, S. mansoni egg patent
infection, malaria, giardiasis, anemia, and fecal occult blood were 36.7%, 16.1%, 44.3%, 65.2%, 21.4%, 50.6%, and
41.2%, respectively. Median VO2max was elevated in those previously treated, compared with those newly recruited
(46.3 versus44mLkg−1min−1,P<0.001).Multivariable-adjusted analysis revealedastrongnegative associationbetween
S. mansoni egg patent infection and VO2max at low altitude (beta coefficient: −3.96, 95% CI: −6.56 to −137, P = 0.004).
This is the first study to document a negative association between S. mansoni infection and aerobic capacity at low
altitudes using the 20mSRT.
INTRODUCTION
Intestinal schistosomiasis, as caused by infection with
Schistosoma mansoni, is an important contributor toward
chronic morbidity in African children as measured by various
methodologies.1–10 However, its impact on diminished exer-
cise tolerance is not well explored. By contrast, the functional
consequence of Schistosoma haematobium–associated ane-
mia has been assessed by the 20-m shuttle run test (20mSRT)
and validated to provide an accurate correlate of aerobic ca-
pacity by the VO2max (measured in mL kg−1 min−1).11
The pathophysiological pathway underlying decreased
physical fitness in children with either form of schistosomiasis
is complex, hinging on immunopathological lesions and
generalized inflammatory responses.12–14 Anemia is a cause
of decreased oxygen carrying capacity and has been asso-
ciated with both heavy and light Schistosoma infections in
childhood.1,2,4,9,15–21 The predominant underlying mechanism
seems to be anemia of inflammation, involving pro-inflammatory
cytokines including tumour necrosis factor (TNF)-alpha and
Interleukin-6.22–24 Other mechanisms include ulcerative pas-
sage of eggs through the intestinal wall, causing extracorpo-
real blood loss, splenic sequestration, and autoimmune
hemolysis.17,25,26
Lake Albert in western Uganda provides the optimumhabitat
for Biomphalaria snails, the intermediate host for S. mansoni,
making it a hub for S. mansoni transmission. Previous studies
have identified egg patent S. mansoni infection prevalences of
up to 82% among children aged 5–10 years living in the re-
gion.27 Since 2004, the control of schistosomiasis-related
morbidity in Uganda has been centered on the targeted,
periodic distribution of praziquantel therapy to school-aged
children older than 4 years and selected “at risk” adult
populations.28 Proxy markers of morbidity have since been
evaluated, including fecal occult blood, anemia, and fecal cal-
protectin testing, quality of life questionnaires, biometry, clinical
palpation and measurement, portable ultrasonography, and
fitness tests.12,29,30
Previous studies investigating the relationship of S. mansoni
infection with physical fitness asmeasured by the 20mSRT have
been inconclusive, limited by small sample sizes, and have not
compared or incorporated altitudinal effects.7,8 Altitude acclima-
tization with an associated increase in red blood cell volumemay
occur at altitudes as low as ∼1,000 m.31 This study aimed to
determine whether S. mansoni infection was associated with
decreased aerobic capacity in Ugandan children living at low
(∼600 m) or high (∼1,000 m) altitudes. It was hypothesized that
S. mansoni infection would correlate with decreased aerobic ca-
pacity inUgandanchildrenand that thisassociationwouldbe less
pronounced in children living at high altitude.
METHODS
Ethics statement and eligibility criteria. Ethical approval
was obtained from the London School of Hygiene & Tropical
Medicine (LSHTM) Ethics Committee (LSHTM number 12034),
Liverpool School of Tropical Medicine (LSTM) Masters Review
Panel (M09-17), and the Vector Control Division, Ministry of
Health, Uganda (VCDREC-082). Children were considered eli-
gible for enrollment if they were aged 7–15 years, medically fit,
had resided in a S. mansoni–endemic area for at least 2 years,
and could provide child assent.
Study setting and population. This studywas carried out in
six S. mansoni–endemic schools within the Buliisa District of
Lake Albert in western Uganda: Biiso (lat. 41.4199, long.
1.7606), Busingiro (lat. 31.4475, long. 1.7354), Bugoigo Islamic
(lat. 31.4122, long. 1.9000), BugoigoPrimary (lat. 31.4167, long.
1.9089), Nyamukuta (lat. 31.4000, long. 1.8683), andWalukuba
*Address correspondence to Amaya L. Bustinduy, Department of
Clinical Research, London School of Hygiene & Tropical Medicine,
KeppelStreet, London,UKWC1E7HT.E-mail: ama.bustinduy@lshtm.ac.
uk
1
(lat. 31.3831, long. 1.8425). Epidemiological data previously
collected within this region provided a useful foundation and
thereby influenced the selection of schools for our study.27,32,33
Buliisa is bordered by Nebbi (north), Masindi (east), Hoima
(south), and theDemocraticRepublicofCongo (west).Biisoand
Busingiro lay at altitudes of 1,004 and 1,062 m, respectively.
The remainder of the schools lay adjacent to Lake Albert, with
an altitude of 616 m. The geographical proximities of the
schools to the lake shoreline are < 1 km for Bugoigo and
Walukuba, and approximately 9 and 14 km for Biiso and Busi-
ngiro, respectively. Egg patent S. mansoni infection preva-
lences among children aged 5–10 years in the villages of
Bugoigo,Walukuba, Biiso, and Busingiro have been previously
identified to be 36.7%, 82.0%, 19.7%, and 8.0% re-
spectively.27 No transmission of S. haematobium has been
documentedonparasitological surveys in thefieldofstudy.27,34
The study involved 305 schoolchildren aged 7–15 years. Of
the 305 schoolchildren, a total of 96 children from Biiso,
Busingiro, andBugoigo Islamic schoolswere followedup from
2 weeks prior. The team had performed an identical armory of
parasitological diagnostic tests and 20-m shuttle run testing,
and had administered praziquantel, albendazole, and, if
malaria-positive, artemether–lumefantrine therapy.
The study team comprised members from LSHTM, LSTM,
and the Vector Control Division, Ministry of Health, Uganda.
Subjects were enrolled following random selection from the
P2 to P6 class registers of each school over a 9-day period in
June 2017. For each village, community mobilizers assisted
with community sensitization before data collection. Three of
the six schools sampled had been recently sensitized by the
preceding LSTM team. Head teacher consent and written
child assent were obtained. The information sheets were
translated into the local Alur dialect and distributed. The ra-
tionale for the study was explained using a local translator.
Forty to 60 children were sampled per day. The principal
investigator, a qualified medical practitioner, assessed each
child’s general health before study participation. Each child
was assigned a unique study identification number whichwas
written on a wristband to be worn by the child during testing.
They were asked a brief series of questions related to their
demographics, medical background, and previous prazi-
quantel administration using Open Data Kit software, LSHTM,
UK, on a tablet device (http://opendatakit.lshtm.ac.uk/odk/).
The frequency of mass drug administration with praziquantel
at each school was recorded following head teacher
questioning.
Anthropometric assessment. Assessment for stunting
was performed using validated charts based on height-for-
age (HFA) Z-score: “stunted” was defined as £ 2 to > 3 SD
below themean and “severely stunted”was defined as £ 3 SD
below the mean.35 Calibrated measurements of weight and
height were obtained by trained field-workers using stan-
dardized scales and a standardized stadiometer, respectively.
The height values obtained were for only a subset of the new
participants and were converted to HFA Z-scores according
to a standardized reference.36 Body mass index (BMI) was
calculated for each child for whom height and weight were
obtained and converted to BMI-for-age (BFA) Z-scores
according to a standardized reference.36 Results were recor-
ded on the standardized data collection form.
Twenty-meter shuttle run test. Each participant un-
dertook a 20mSRT.11 The test was performed in the school
grounds on a clear and level playing field during school hours
to maximize convenience and minimize disruption to the
school day program. Six to 12 children were tested at any one
time. For every four children, one observer was ascribed to
ensure adequate monitoring of their performance. Careful in-
structions were given using a local translator, and a brief
demonstration of the test was performed by the principal in-
vestigator before testing. All children were kept well hydrated,
and water and sugary snacks were made available.
Materials used included two premeasured 20-m ropes,
markers, a microphone, a portable speaker, and a tablet de-
vice with a relevant application for the 20mSRT (Bleep Fitness
Test; Aspectica Ltd., Bath, Somerset, UK). Colored bibs were
worn by the study participants for ease of identification. Each
fitness scorewas then translated intoVO2max (mLkg−1min−1)
using a validated reference.11
Field-based parasitological diagnostic testing and
treatment. A single urine specimen was obtained from each
child and tested for the presence of urine circulating cathodic
antigen (urine-CCA; Rapid Medical Diagnostics, Pretoria,
South Africa). Urine-CCA has the advantage of detecting
light intensity infections which may be missed using the
traditional Kato–Katz technique.37 The test band reaction
intensitywas semiquantitatively graded as negative (−), trace
positive (tr), single positive (+), double positive (++), and triple
positive (+++).
The presence of S. mansoni infection was determined by
duplicate Kato–Katz thick fecal smears (each 41.7 mg) pre-
pared by trained field technicians in accordance with Katz
et al.38Kato–Katz examination indicates infectionwithmature,
egg-shedding worms. The technique was used to provide
further information into the level of egg excretion, which is
likely a proxy marker of bowel morbidity in addition to in-
fection. Microscopy with a natural light source was used for
infield interpretation on the day of testing. Schistosoma
mansoni egg counts and the number of eggs per gram of stool
based on the mean of the two specimens were documented.
Each fecal specimen was tested for the presence of Giardia
duodenalis infection using the Giardia/Cryptosporidium Quik
Chek test (TECHLAB®, Inc., Blacksburg, VA), and human he-
moglobin and transferrin using the Transferrin/FOB Combo
Rapid Test Cassette (Hangzhou AllTest Biotech Co., Ltd.,
Zhejiang, China).
Capillary blood sampling was used to determine the total
hemoglobin level (HemoCue AB, Angelholm, Sweden) and
screen for malaria infection (Standard Diagnostics BIOLINE
Malaria Ag P.f./Pan, Alere, TM.). Follow-up children were not
screened for malaria, given the likelihood of persistent anti-
genemia following recent testing.
Of the new participants, those who tested positive for
schistosomiasis on urine-CCA and/or malaria were ad-
ministered standardized therapy for schistosomiasis and/or
malaria, respectively, in keeping with national guidelines. All
participants were administered albendazole therapy. Of the
follow-up participants, only those who tested positive for
urine-CCA were administered praziquantel therapy, given
their recent treatment by thepreceding team.Nochildrenwere
identifiedasbeing unwell or required referral to the local level 2
health care facility.
Data management and statistical analysis. All data col-
lected were de-identified, entered into Microsoft Excel (Ver-
sion16.13.1;MicrosoftCorp., Redmond,WA) or LSHTMOpen
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Data Kit software, and stored on an encrypted universal serial
bus (USB) device. Data analysis was performed using STATA
14.2 (StataCorp LLC, College Station, TX) on those for whom
20mSRT data were obtained. Separate analyses of the entire
cohort and of the follow-up participants were conducted.
Descriptive analyseswith stratificationsby school and altitude
(low:∼600m, high:∼1,000m) were performed. Wilcoxan rank
sum, Kruskal–Wallis, Spearman’s correlation, Chi-squared
tests, paired t-test, and analysis of variance (ANOVA) were
used to identify differences between schools and altitudes.
Linear regression was used to determine the unadjusted
associations between independent covariates and the
dependent variable, VO2max (continuous). Independent
covariates of interest includedeggpatentS.mansoni infection
(dichotomous), malaria infection (dichotomous), fecal occult
blood (ordinal), anemia (dichotomous), stunting based on
validated charts (dichotomous) andHFAZ-score £2SDbelow
the mean (dichotomous), and wasting defined by BFA Z-
score £ 2 SD below the mean (dichotomous).28,35,36 Anemia
was defined according to standardized cutoffs for age:
< 11.5 g dL−1 (5–11 year) and < 12.0 g dL−1 (12–14 year), and
adjusted for altitude using the equation “Hb (g dL−1) − 0.2 g
dL−1” for an altitude approximating 1,000 m.39 Logistic re-
gression was used to examine the unadjusted associations
between the aforementioned covariates and dependent vari-
ables of fecal occult blood, anemia, and stunting (by validated
charts). Multivariable-adjusted linear regression was per-
formed using VO2max as the dependent variable, and
multivariable-adjusted logistic regression analyses were
undertaken using anemia, fecal occult blood, and stunting
each as the dependent variable. Model selection was per-
formed using a stepwise procedure, followed by Akaike’s
information criterion (AIC) as the model selection criterion.
The model which minimized the AIC was selected. All anal-
yses were stratified by gender and altitude.
RESULTS
Participation. Six schools within the Buliisa District were
consecutively sampled: Biiso (n = 48), Busingiro (n = 46),
Bugoigo Islamic (n=48), BugoigoPrimary (n=61), Nyamukuta
(n = 61), and Walukuba (n = 40). Of 305 children who partici-
pated, 304 completed the 20mSRT and were included within
the final analysis. Only one child did not complete the 20mSRT
because of a minor foot injury. Five children did not provide
fecal samples and seven children did not provide urine for
testing. Malaria, capillary hemoglobin, and fecal occult blood
were limited by resource availability, given the diversion of
their use by the local clinic. Of 104 children sampled at
baseline, 96 children completed the 20mSRT at follow-up
(92.3%) and were included within the final analysis. The main
reason for the lack of follow-up was the absence from school
on the day of testing (Table 1). The remaining 208 children
includedwithin the final analysiswere those newly recruited to
the study.
Descriptive analyses. The age, gender, and parasitology
distributionswere similar between schools, with the exception
of malaria (P = 0.003, Table 1, Figure 1). The prevalence of
S. mansoni may have been confounded by the variable dis-
tances of the schools from the lake. The prevalence of Plas-
modium falciparummalariawas significantly higher at 1,000m
than at 600 m altitudes (P = 0.015, Table 2, Figure 1).
Prevalence of S. mansoni by urine-CCA was highest (80.5%),
followed byP. falciparum (65.2%),S.mansoni by egg patency
(44.3%), and G. duodenalis infection (21.3%). All of the
schools studied had received mass drug administration with
praziquantel within the preceding 12 months. Overall, 34.5%
of children were classified as anemic (n = 86/249) and 41.2%
of children had fecal occult blood in the stool. There were no
differences in the prevalence of anemia or fecal occult blood
and median hemoglobin between schools (Table 1).
Anthropometrics and nutritional status. Acute and
chronic malnutrition were identifiedwithin all schools. Overall,
36.7% of children were stunted according to a HFA Z-score
£ 2 SD below the mean (n = 79/215) and 16.7% were stunted
according to validated charts (n = 49/293). Of the latter, 1%
were severely stunted based on a HFA score £ 3 SD below the
mean (n = 3/293, Table 1).
Performance in the 20mSRT. Careful instructions and a
test demonstration were provided before shuttle run testing.
Overall, the 20mSRT was well understood with very few false
starts and trips observed. If either occurred, a rest period was
provided and testing was recommenced. Overall, the median
VO2max was 45.4 mL kg−1 min−1 (interquartile range [IQR]:
42.9–48 mL kg−1 min−1) with higher values obtained by males
than females (47.5 versus 43.9 mL kg−1 min−1, P < 0.001,
Table 1). Those children living at high altitude demonstrated a
higher median VO2max than those residing at low altitude
(46.3 versus 44.8 mL kg−1 min−1, P = 0.031, Supplemental
Table 1).
When compared with a Canadian cohort, males demon-
strated lower VO2max for all ages.11 Females demonstrated a
lower VO2max up until the age of 12 years, after which an
upward trend was observed. Figure 2 illustrates the differ-
ences between the Canadian and study cohorts by age and
gender, and incorporates data from a Kenyan cohort for
comparison.2 Outliers at the ages of 7 years (n = 3) and 15
years (n = 3) were excluded (Supplemental Table 3).
Associations between infection, nutritional status, and
aerobic capacity. Unadjusted and multivariable-adjusted
analyses examining VO2max as an outcome were performed
using linear regression.Covariates studied includedS.mansoni
egg patent infection, fecal occult blood, malaria, and stunting
(based on validated charts). The analyses were stratified by
gender because of the differences in aerobic capacity be-
tween males and females (Supplemental Table 3), and by al-
titude for the purposes of this study. Model selection was
performed using a stepwise procedure, followedbyAIC as the
model selection criterion. The model with the lowest AIC was
selected. Tables 2and3andSupplemental Table4 summarize
these findings.
On unadjusted analysis, S. mansoni egg patent infection
was a negative predictor of VO2max (Coeff: −1.28, 95% CI:
−2.20 to 0.36, P = 0.007). Increasing S. mansoni intensity of
infection correlated with decreasing VO2max (Coeff: −0.496,
95% CI: −0.862 to −0.132, P < 0.05). No other covariates
demonstrated significant associations with VO2max. The
correlation between S. mansoni egg patent infection and
VO2max remained when adjusted for the presence of fecal
occult blood, malaria, stunting (based on validated charts),
and anemia (Coeff: −4.91, 95% CI: −6.31 to 2.07, P < 0.001,
Table 2). Similarly, for girls, S. mansoni egg patent infection
was associated with VO2max on unadjusted (Coeff: −1.91,
95%CI: −3.12 to −0.70,P = 0.002) andmultivariable-adjusted
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(Coeff: −5.04, 95% CI: −8.80 to −1.28, P = 0.011) analyses
(Supplemental Table 4). For boys, no significant correlations
with VO2max were identified. For schools residing at low al-
titudes, S. mansoni egg patent infection negatively correlated
withVO2maxonbothunadjusted (Coeff:−1.30, 95%CI:−2.39
to −0.21, P = 0.02) and multivariable-adjusted (Coeff: −3.96,
95% CI: −6.56 to −1.368, P = 0.004) analyses. For schools
residing at high altitude, malaria infection positively correlated
with VO2max on both unadjusted (Coeff: 2.83, 95% CI:
0.49–5.17, P = 0.019) and multivariable-adjusted (Coeff: 5.52,
95% CI: 0.08–10.96, P = 0.047) analyses (Table 3).
Associations between infection, anemia, fecal occult
blood, and nutritional status. Logistic regression was used
to explore the association between fecal occult blood, ane-
mia, and stunting with infection status, with each covariate
being recorded as dichotomous variables. Schistosoma
mansoni egg patent infection positively correlated with fecal
occult blood (OR: 0.04, 95% CI: 4.01–20.37, P < 0.05).
Schistosoma mansoni egg patent infection was positively
associated with anemia on unadjusted analysis (OR: 1.85,
95% CI: 1.08–3.15, P = 0.02), as was fecal occult blood (OR:
1.51, 95% CI: 1.11–2.07, P = 0.01). Multivariable-adjusted
analysis revealed fecal occult blood to be the only positive
predictor of anemia (OR: 1.96, 95% CI: 1.11–3.43, P = 0.02,
Supplemental Figure 1).
Logistic regression was also used to analyze stunting
(based on validated charts) as an outcome. Schistosoma
mansoni egg patent infection positively correlated with
stunting (OR: 2.49, 95%CI: 1.30–4.77,P=0.01) onunadjusted
analysis; however, this association did not remain when ad-
justed for the presence of fecal occult blood, malaria, and
anemia (OR: 0.75, 95%CI: 0.17–3.39, P = 0.71, Supplemental
Table 5, Supplemental Figure 1).
Comparison between baseline and follow-up. The
prevalence of egg patent S. mansoni infection was similar at
baseline and follow-up (20.8% versus 25.0%, P = 0.053).
Median hemoglobin was significantly higher at follow-up (10.7
versus 10.2 g dL−1, P < 0.001, Figure 2). Similarly, the preva-
lence of anemia was lower at follow-up (69.3% versus 72.9%,
P = 0.001), particularly for those residing at low altitude. There
was no difference in the prevalence of fecal occult blood be-
tween the two time-points (22.9% versus 31%, P = 0.584,
Supplemental Table 2).
In those residing at low altitude, median VO2max declined
between baseline and follow-up (47.0 versus 48.7 mL kg−1
min−1, P < 0.001); however, it remained similar between the
two time-points in those residing at high altitude (46.3 versus
46.3mL kg−1min−1,P= 0.349, Supplemental Table 2). Median
VO2max was higher in those who had been treated 2 weeks
prior at baseline, compared with those who were newly
recruited to the study (46.3 mL kg−1 min−1, IQR: 44.6–
49.7 mL kg−1 min−1 versus 44 mL kg−1 min−1, IQR: 42.1–
47.5 mL kg−1 min−1, P < 0.001, Figure 3).
DISCUSSION
Chronic childhood morbidity secondary to S. mansoni in-
fection has been previously overshadowed by a lack of fea-
sible morbidity metrics adaptable to the pediatric population
livingwithin resource-poor settings. This studyhasshown that
S. mansoni egg patent infection is associated with decreased
aerobic capacity in Ugandan schoolchildren, with lower aer-
obic capacities seen in Ugandan than Canadian children. The
20mSRTproved to bea feasible andeasily implementable tool
that may be harnessed for the identification of S. mansoni–
related morbidity within the school setting.
FIGURE 1. (A) Prevalence of egg patent Schistosoma mansoni infection according to school and altitude. (B) Prevalence of malaria infection
according to altitude. This figure appears in color at www.ajtmh.org.
TABLE 2
Linear regression models with VO2max as the outcome
Unadjusted analysis Multivariable-adjusted analysis
Coefficient 95% CI P-value Coefficient 95% CI P-value
Schistosoma mansoni egg patent
infection*
−1.279 −2.199 −0.360 0.007 −4.191 −6.312 −2.070 < 0.001
Fecal occult blood −1.181 −0.767 0.404 0.542 0.404 −0.533 1.342 0.392
Malaria† 0.142 −1.057 1.341 0.815 −0.811 −2.824 1.203 0.424
Stunting‡ −0.534 −1.650 0.583 0.348 −0.615 −2.934 1.704 0.598
Anemia§ −0.650 −1.663 0.363 0.208 0.364 −1.595 2.323 0.711
Statistically significant differences (P £ 0.05) indicated in bold.
* As per dual Kato–Katz examination.
† As per malaria rapid diagnostic testing.
‡ According to validated stunting charts based on height-for-age Z-score £ 2 SD below mean.35
§ As per standardized hemoglobin cutoffs for age: < 11.5 g dL−1 (5–11 years) and < 12.0 g dL−1 (12–14 years). Hemoglobin adjusted for altitude.39 For multivariable-adjusted analysis, n = 68.
P-value = 0.009. R2 = 0.2142. Adjusted R2 = 0.1508. Akaike’s information criterion = 373.447.
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Negative correlations between all S. mansoni infection in-
tensities and VO2max were found in our study, highlighting
the important contribution of light-intensity infections to
S. mansoni–related morbidity.3,4 These findings were based
on the traditional Kato–Katz method which can miss up to
20–40% of active infections.40 However, in the presence of
infections of moderate–high intensity as was predominantly
the case in this study, both urine-CCA and parasitological
examination maintain high levels of accuracy.41
The pathway between S. mansoni infection and decreased
aerobiccapacity ismultifactorial andcomplex.Anemia is aknown
downstreameffector ofS.mansoni infectionandhasbeenshown
to be associated with decreased aerobic capacity.2 Fecal occult
blood isaproxymarkerof intestinal inflammationandmechanism
for anemia in S. mansoni infection.26,29,42 Schistosoma mansoni
egg patent infection and fecal occult blood both positively cor-
related with anemia in our study. Furthermore, S. mansoni egg
patent infectionwas linkedwith stunting; another knownpathway
for anemia causation inS.mansoni infection.2 Figure 4 integrates
the findings of this study with current knowledge to suggest a
potential, albeit-simplified, pathophysiological basis for reduced
physical fitness in children living in S. mansoni–endemic areas.
Previous studies have demonstrated a reduction in anemia,
nutrition-related morbidity, and fecal occult blood, and an in-
crease in physical performance following praziquantel
therapy.18,23,29,33,43,44 A reassuring decline in the prevalence of
anemia was noted in the follow-up cohort after treatment for
schistosomiasis at baseline. Furthermore, higher aerobic capac-
itieswereseen in thosewhohadbeen recently treated, compared
with those who were newly recruited to the study, emphasizing
the reversibility of functional morbidities. It is important to note,
however, that disentangling chronic morbidity and the effects of
interventions in low-resource settings is a challenging task.
Chronic morbidity is confounded by polyparasitic infections, nu-
tritional deficiencies, and numerous other factors, such as so-
cioeconomic status and food scarcity, which were unable to be
accounted for within the constraints of this study.3–5,45,46
Those children residing at high altitude exhibited higher aero-
bic capacities than those residing at low altitude. In the former,
S. mansoni infection did not have a negative effect on aerobic
capacity. With increasing altitude, barometric pressure and at-
mospheric partial pressure of oxygen decline, resulting in an in-
crease inerythropoietinproduction. Thisoccurs via the releaseof
hypoxia-inducible factor alpha. Erythropoietin stimulates the
FIGURE 2. Comparison of mean VO2max between Ugandan (study) and Kenyan and Canadian cohorts by gender and age (Canadian and
Ugandan data sourced from Leger et al.11 and Bustinduy et al.,2 respectively). This figure appears in color at www.ajtmh.org.
TABLE 3
Linear regression models with VO2max as the outcome, stratified by altitude
Unadjusted analysis Multivariable-adjusted analysis
Coefficient 95% CI P- value Coefficient 95% CI P-value
Schistosoma mansoni egg patent infection*
Low altitude −1.299 −2.389 −0.208 0.020 −3.962 −6.556 −1.368 0.004
High altitude −0.971 −2.712 0.770 0.271 0.452 −5.102 6.007 0.866
Fecal occult blood
Low altitude −0.610 −1.349 0.128 0.104 −0.226 −1.362 0.911 0.690
High altitude 0.592 −0.333 1.518 0.205 0.694 −1.094 2.482 0.424
Malaria†
Low altitude −0.938 −2.320 0.444 0.182 −2.121 −4.390 0.148 0.066
High altitude 2.832 0.494 5.170 0.019 5.524 0.084 10.964 0.047
Stunting‡
Low altitude −0.448 −1.749 0.853 0.498 −0.126 −2.715 2.463 0.922
High altitude −0.719 −2.875 1.438 0.510 −0.842 −6.230 4.547 0.746
Anemia§
Low altitude −0.924 −2.145 0.297 0.137 0.891 −1.418 3.201 0.440
High altitude −0.326 −2.076 1.424 0.711 −1.834 −5.384 1.717 0.291
AIC = Akaike’s information criterion. Statistically significant differences (P £ 0.05) indicated in bold.
* As per dual Kato–Katz examination.
† As per malaria rapid diagnostic testing.
‡ According to validated stunting charts based on height-for-age Z-score £ 2 SD below mean.35
§ As per standardized hemoglobin cutoffs for age: < 11.5 g dL−1 (5–11 years) and < 12.0 g dL−1 (12–14 years). Hemoglobin adjusted for altitude.39 Formultivariable-adjusted analysis, low altitude:
n = 45. P-value = 0.022. R2 = 0.277. Adjusted R2 = 0.184. AIC = 246.900. High altitude: n = 23. P-value = 0.202. R2 = 0.326. Adjusted R2 = 0.128. AIC = 125.111.
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bone marrow to increase iron turnover and production of nu-
cleated red blood cells, thereby increasing red blood cell
mass.47–49 These adaptations may transpire at altitudes as low
as ∼1,000 m.31 Such acclimatization may have dampened the
deleterious effect of S. mansoni infection on aerobic capacity in
the children living at a higher altitude.
This study has several limitations. The small sample size
achievablewithin the time frame has limited the strength of the
inferences one can make from the findings, particularly with
regard to baseline and follow-up cohorts. Nevertheless, the
sample size calculation performed at the outsetwas achieved,
and these findings provide a robust indication for further
investigation into the pathway linking S. mansoni infection with
physical fitness in children living inS.mansoni–endemic areas. In
addition, testing resource availability was limited because of the
unforeseen need of the local clinic to use the resources for
medical indications. No specificmethod for ensuring the children
reached theirmaximal aerobic capacitywasused. Suchmethods
are usually time-consuming and cumbersome, and were there-
fore purposely avoided as a means of maintaining the external
validity of the 20mSRT as a school-based morbidity metric. The
time period between baseline and follow-up testing was brief,
limiting thespeculationsonecouldmakewith regard tooutcomes
following previous exposure to infection and treatment.
FIGURE 3. (A) Median hemoglobin at baseline and follow-up. (B) Scatter plot of VO2max for follow-up and new participants with median and
interquartile range. This figure appears in color at www.ajtmh.org.
FIGURE 4. Conceptual pathway for impaired physical fitness in Schistosoma mansoni infection in children. Note: broken arrows represent
relationships described elsewhere. This figure appears in color at www.ajtmh.org.
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Areas requiring further investigation include1) thedevelopment
of more rigorous diagnostic tests capable of detecting light in-
fections and demonstrating antigenic cure, thereby illustrating
treatment efficacy; 2) the innovation and application of feasible
morbidity metrics with the ability to identify sequelae of S. man-
soni infections of all intensities; 3) the degree of impact of various
altitudes on VO2max and interplay of these associations with
parasitic infectionsandanemia; and4) extendedbaseline–follow-
up comparisons to delineate the effects of treatment on physical
fitness within S. mansoni–endemic areas at different altitudes.
This is the first study to document a relationship between S.
mansoni infectionanddecreasedaerobiccapacityathighand low
altitudes. Altitude acclimatization may be partially protective of
this effect. Although the cause of impaired physical performance
is multifactorial, this study provides evidence to support the im-
portant contribution that S. mansoni infection has toward child-
hood morbidity. The lower aerobic capacities seen in the
Ugandan children than in Kenyan and Canadian children em-
phasize the inherent need for morbidity assessment in children
residingwithinS.mansoni–endemic areas. Furthermore, a recent
malacological survey identified schistosomiasis transmission in
regions with an altitude beyond 1,400 m, indicating the need for
the geographical expansion of morbidity assessment.34,50,51
Widespread deployment of the 20mSRT throughout school set-
tings represents a promising means by which schistosomiasis-
related childhood morbidity may be rapidly detected and man-
aged appropriately within these areas.
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S1 Table. Demographic, Hematologic, Immunochemical, Parasitological & 20m-Shuttle Run Test Findings in Villages of the Buliisa District at Low 
Altitude Compared with High Altitude. 
Parameter 
Total  
(n=304) 
Low Altitude  
(n=210) 
High Altitude 
(n=94) P Value* 
DEMOGRAPHY 
Median age in years (interquartile range) 11 (10-12) 11 (10-13) 11 (10-12) 0.876 
% Female (n) 49.7 (151/304) 50.0 (105/210) 48.9 (46/94) 0.864 
ANTHROPOMETRY 
Median height in centimeters (interquartile range) 134 (128.5-140.5) 135.5 (128.7-142.1) 133 (127.6-137.6) 0.046 
% Stunted by HFA Z-score (n)** 36.7 (79/215) 39.5 (60/152) 30.2 (19/63) 0.197 
% Stunted by validated charts (n)*** 16.7 (49/293) 16.5 (33/200) 17.2 (16/93) 0.450 
% Stunted (n) 15.7 (46/293) 15.0 (30/200) 17.2 (16/93) 
 % Severely stunted (n) 1.0 (3/293) 1.5 (3/200) 0.0 (0/93) 
Median body mass index (interquartile range) 16.1 (14.8-17.3) 16.1 (14.8-17.3) 14.8 (13.2-16.3) 0.435 
% Wasted (n)**** 11.8 (8/68) 12.1 (8/66) 0.0 (2/2) 0.600 
HAEMATOLOGY 
Median hemoglobin in g dL
-1
 
(interquartile range)# 
11.6  
(10.7-12.4) 
12.1 
(11.4-12.7) 
12.0 
(11.4-12.7) 
0.739 
% Anemic (n)#  34.5 (86/249) 33.0 (57/173) 38.2 (29/76) 0.426 
IMMUNOCHEMICAL 
% Fecal occult blood test positive (n) 41.2 (61/148) 42.6 (40/94) 38.9 (21/54) 0.654 
PARASITOLOGY 
Schistosomiasis 
% S. mansoni infection by urine-CCA (n)~ 80.5 (231/287) 80.3 (159/198) 80.9 (72/89) 0.906 
% Egg patent S. mansoni infection (n)~~ 44.3 (127/288) 47.0 (94/200) 37.5 (33/88) 0.135 
Mean epg (95% confidence interval) 449.5 (330.1-568.9) 527.2 (366.4-687.9) 273.1 (137.5-408.8) 0.133 
S. mansoni intensity~~ 
 
% Negative (n) 55.9 (161/288) 53.0 (106/200) 62.5 (55/88) 
 
% Light (n) 10.1 (29/288) 12.0 (24/200) 5.7 (5/88) 
 
% Medium (n) 11.8 (34/288) 11.0 (22/200) 13.6 (12/88) 
 
% Heavy (n) 22.2 (64/288) 24.0 (48/200) 18.2 (16/88) 
 
Malaria 
% Malaria (n)^ 65.2 (122/187) 60.9 (81/133) 75.9 (41/54) 0.051 
% P. falciparum (n) 65.2 (122/187) 60.9 (81/133) 75.9 (41/54) 0.015 
% Mixed (n) 11.2 (21/187) 10.5 (14/133) 13.0 (7/54) 0.768 
Giardiasis 
 
% Giardia duodenalis infection (n)^^ 21.4 (63/294) 22.2 (45/203) 19.8 (18/91) 0.128 
20M-SHUTTLE RUN TEST         
Median VO2max in mL kg
-1
 min
-1
 (interquartile range) 45.4 (42.9-48.0) 44.8 (42.1-47.5) 46.3 (43.4-48.7) 0.031 
Males 47.5 (43.9-49.0) 46.4 (43.8-49.0) 47.9 (46.0-49.6) 0.078 
Females 43.9 (41.5-46.3) 43.9 (41.5-45.7) 44.3 (42.9-46.3) 0.258 
 
*Indicates significance of differences among the villages by Kruskal-Wallis or Chi-squared analysis, paired T test or ANOVA. Statistically significant differences (P ≤ 0.05) 
indicated in bold. **As defined by height-for-age Z-scores ≤ 2 S.D. below mean.
37
 ***According to validated stunting charts based on height-for-age Z-score: 'stunted' (≤ 2 - > 3 
S.D. below mean), 'severely stunted' (≤ 3 S.D. below mean).
36
 ****As defined by BMI-for-age Z-scores ≤2 S.D. below mean.
37
 #As per standardised hemoglobin cut-offs for 
age: < 11.5 g dL
-1
 (5 - 11y), < 12.0 g dL
-1
 (12 - 14y). Hemoglobin adjusted for altitude.
40
 ~As per urine-cathodic circulating antigen testing. ~~As per dual Kato-Katz 
examination. Intensity defined by epg: 1 - 99 = light; 100  -399 = medium, ≥ 400 = heavy.
29
 ^As per malaria rapid diagnostic testing. ^^As per Giardia/Cryptosporidium Quik 
Chek test. 
 
 
S2 Table. Demographic, Hematologic, Anthropometric, Immunochemical, Parasitological & 
20m-Shuttle Run Test Findings in Baseline & Follow-up Cohorts. 
 
Parameter 
Baseline 
(n=96) 
Follow-up 
(n=96) P Value* 
DEMOGRAPHY 
Median age in years (interquartile range) 11 (9.5-12) 11 (9.5-12) 
 
Low altitude 11 (9-12) 11 (9-12) 
High altitude 11 (10-12) 11 (10-12) 
% Female (n) 51.0 (49/96) 51.0 (49/96) 
Low altitude 48.5 (16/33) 48.5 (16/33) 
High altitude 52.4 (33/63) 52.4 (33/63) 
HAEMATOLOGY 
Median hemoglobin in g dL
-1
, adjusted 
(interquartile range)# 
10.2 (9.6-11.7) 10.7 (9.7-12.1) <0.001 
Low altitude 11.8 (11.0-12.3) 12.5 (11.9-13.1) <0.001 
High altitude 11.5 (10.6-11.9) 112.0 (11.2-12.6) <0.001 
% Anemic, adjusted (n)# 47.9 (23/48) 69.3 (25/75) 0.001 
Low altitude 42.9 (9/21) 20.8 (5/24) 0.002 
High altitude 51.9 (14/27) 39.2 (20/51) 0.098 
IMMUNOCHEMICAL 
% Fecal occult blood test positive 22.9 (11/48) 31.0 (18/58) 0.584 
Low altitude 28.6 (6/21) 35.0 (7/20) 0.774 
High altitude 18.5 (5/27) 29.0 (11/38) 0.137 
PARASITOLOGY 
% S. mansoni infection by urine-CCA (n)~ 62.5 (30/48) 76.1 (67/88) <0.001 
Low altitude 57.1 (12/21) 69.0 (20/29) 0.005 
High altitude 66.7 (18/27) 79.7 (47/59) 0.001 
% Egg patent S. mansoni Infection (n)~~ 20.8 (10/48) 25.0 (22/88) 0.053 
Low altitude 28.6 (6/21) 17.2 (5/29) N/A 
High altitude 14.8 (4/27) 28.8 (17/59) 0.006 
Mean eggs per gram 
(95% confidence interval)~~ 
49.8 (-13.1-112.6) 251.5 (86.4-416.5) 0.375 
Low altitude 75.4 (-64.6-215.5) 344.7 (-41.6-731.0) 0.277 
High altitude 29.8 (-11.6-71.1) 205.6 (47.1-364.1) 0.663 
S. mansoni intensity~~  
% Negative (n) 79.2 (38/48) 75.0 (66/88) 
 
% Light (n) 14.6 (7/48) 5.7 (5/88) 
% Medium (n) 2.1 (1/48) 6.8 (6/88) 
% Heavy (n) 4.2 (2/48) 12.5 (11/88) 
Low Altitude 
% Negative (n) 71.4 (15/21) 82.8 (24/29) 
 % Light (n) 23.8 (5/21) 3.5 (1/29) 
% Medium (n) 0.0 (0/21) 0.0 (0/29) 
% Heavy (n) 4.8 (1/21) 13.8 (4/29) 
High Altitude 
% Negative (n) 85.2 (23/27) 71.2 (42/59) 
 
% Light (n) 7.4 (2/27) 6.8 (4/59) 
% Medium (n) 3.7 (1/27) 10.2 (6/59) 
% Heavy (n) 3.7 (1/27) 11.9 (7/59) 
% Giardia duodenalis infection (n)^^ 20.8 (10/48) 14.9 (14/94) 1.000 
Low altitude 13.3 (3/21) 12.5 (4/32) 0.732 
High altitude 25.9 (7/27) 16.1 (10/62) 0.992 
20M SHUTTLE RUN TEST 
Median VO2max in mL kg
-1
 min
-1
 
(interquartile range) 
47.45 (45.4-50.3) 46.3 (43.9-49.1) 0.001 
Low altitude 48.7 (46.3-52.0) 47.0 (43.9-48.7) <0.001 
High altitude 46.3 (43.9-48.7) 46.3 (43.9-49.5) 0.349 
 
Associations determined by linear regression. *Indicates significance of differences among the villages by 
Kruskal-Wallis or Chi-squared analysis, paired T test or ANOVA. Statistically significant differences (P ≤ 0.05) 
indicated in bold. #As per standardised hemoglobin cut-offs for age: < 11.5 g dL
-1
 (5 - 11y), < 12.0 g dL
-1
 (12 - 
14y). Hemoglobin adjusted for altitude.
40
 ~As per urine-cathodic circulating antigen testing. ~~As per dual Kato-
Katz examination. Intensity defined by eggs per gram (epg): 1 - 99 = light; 100 - 399 = medium, ≥ 400 = heavy.
29
 
^^As per Giardia/Cryptosporidium Quik Chek test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S3 Table. Comparison of Mean VO2max between Study Participants & Reference Canadian 
Cohort. 
 
Age Gender 
Canadian Cohort Study Cohort 
P Value 
n Mean VO2max (S.D.) n Mean VO2max (S.D.) 
7 
Male 297 51.23 (3.34) 2 46.30 (3.39) <0.001 
Female 299 50.26 (2.63) 1 N/A N/A 
8 
Male 303 51.67 (3.91) 9 44.66 (4.03) <0.001 
Female 308 49.82 (3.44) 14 42.33 (3.05) <0.001 
9 
Male 322 51.54 (4.39) 20 47.34 (4.28) <0.001 
Female 322 49.20 (3.24) 22 44.42 (2.77) <0.001 
10 
Male 404 51.64 (4.23) 30 47.32 (3.75) <0.001 
Female 335 46.84 (2.76) 28 44.53 (4.10) 0.006 
11 
Male 386 51.13 (4.53) 23 46.47 (3.65) <0.001 
Female 382 47.51 (4.04) 22 43.87 (4.18) <0.001 
12 
Male 341 51.92 (5.16) 29 46.95 (3.78) <0.001 
Female 292 46.65 (4.17) 29 44.72 (3.44) 0.005 
13 
Male 325 50.10 (5.21) 19 46.29 (3.51) <0.001 
Female 298 44.42 (4.76) 19 43.05 (4.03) 0.1568 
14 
Male 289 50.11 (5.20) 20 45.92 (3.86) <0.001 
Female 260 41.65 (4.72) 16 43.85 (3.57) 0.026 
15 
Male 333 50.20 (6.07) 1 48.80 (N/A) <0.001 
Female 260 41.16 (5.07) 1 41.50 (N/A) N/A 
 
Canadian data obtained from Leger et al., 1988. Differences determined by one-way T test. Statistically 
significant differences (P ≤ 0.05) indicated in bold. S.D. = Standard Deviation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S4 Table. Linear Regression Models with VO2max as the Outcome, Stratified by Gender. 
  Unadjusted Analysis Multivariable-adjusted Analysis 
 Coefficient 95% CI P Value Coefficient 95% CI P Value 
S. mansoni egg patent infection* 
Males -0.842 -2.084 0.400 0.182 -2.407 -5.150 0.337 0.083 
Females -1.912 -3.123 -0.700 0.002 -5.038 -8.794 -1.283 0.011 
Fecal Occult Blood 
Males -0.077 -0.878 0.724 0.848 0.090 -1.233 1.412 0.891 
Females -0.442 -1.234 0.349 0.269 0.343 -0.988 1.673 0.601 
Malaria^ 
Males -0.493 -2.039 1.054 0.529 -0.877 -3.524 1.770 0.504 
Females 0.759 -0.942 2.460 0.378 -0.260 -3.592 3.071 0.874 
Stunting~ 
Males -0.229 -1.966 1.508 0.795 -0.366 -3.541 2.809 0.815 
Females -0.345 -1.678 0.987 0.609 -1.251 -4.586 2.085 0.448 
Anemia# 
Males 0.134 -1.261 1.529 0.849 1.731 1.000 4.462 0.205 
Females -1.264 -2.601 0.072 0.063 -0.311 -3.444 2.822 0.840 
 
Statistically significant differences (P ≤ 0.05) indicated in bold. *As per dual Kato-Katz examination. ^As per 
malaria rapid diagnostic testing. ~According to validated stunting charts based on height-for-age Z-score ≤ 2 S.D. 
below mean.
36
 #As per standardised hemoglobin cut-offs for age: < 11.5 g dL
-1
 (5 - 11y), < 12.0 g dL
-1
 (12 - 14y). 
Hemoglobin adjusted for altitude.
40
 For multivariable-adjusted analysis: Males: n = 36. P Value = 0.257. R-
squared = 0.188. Adjusted R-squared = 0.053. AIC = 195.429. Females: n = 32. P Value = 0.052. R-squared = 
0.330. Adjusted R-squared = 0.201. AIC = 176.918.
S5 Table. Linear Regression Models with Stunting (by validated charts) as the Outcome. 
 
  Unadjusted Analysis Multivariable-adjusted Analysis 
  Odds Ratio 95% CI P Value Odds Ratio 95% CI P Value 
S. mansoni egg patent infection* 2.491 1.302 4.771 0.006 0.752 0.167 3.390 0.711 
Fecal occult blood 1.292 0.867 1.927 0.208 1.215 0.623 2.369 0.568 
Malaria^ 0.651 0.307 1.382 0.264 0.681 0.181 2.560 0.570 
Anemia# 1.391 0.665 2.908 0.381 1.233 0.322 4.726 0.760 
 
Statistically significant differences (P ≤ 0.05) indicated in bold. *As per dual Kato-Katz examination. ^As per 
malaria rapid diagnostic testing. #As per standardised hemoglobin cut-offs for age: < 11.5 g dL
-1
 (5-11y), < 12.0 g 
dL
-1
  (12-14y). Hemoglobin adjusted for altitude.
40
 For multivariable-adjusted analysis: AIC = 73.21548. n = 70. P 
value = 0.92. Pseudo R-squared = 0.0144. likelihood ratio chi-squared test = 0.92. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S6 Figure. Adjusted Odds Ratios for Anemia (A) and Stunting (B; by validated charts).  
 
 
 
 
 
 
The final models were controlled for (a) S. mansoni egg patent infection, fecal occult blood, malaria and stunting 
(by validated charts), & (b) S. mansoni egg patent infection, fecal occult blood, malaria and anemia. *OR 1.96; 
95% CI 1.11 - 3.43, P = 0.020. 
 
 (A) (B) 
